News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
244,635 Results
Type
Article (6326)
Company Profile (17)
Press Release (238292)
Section
Business (87463)
Career Advice (467)
Deals (16400)
Drug Delivery (8)
Drug Development (21418)
Employer Resources (30)
FDA (4341)
Job Trends (4304)
News (130350)
Policy (8655)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (306)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16459)
ALS (19)
Alzheimer's disease (254)
Antibody-drug conjugate (ADC) (11)
Approvals (4366)
Artificial intelligence (41)
Autoimmune disease (4)
Automation (2)
Bankruptcy (104)
Best Places to Work (3049)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (8)
Breast cancer (50)
Cancer (468)
Cardiovascular disease (22)
Career advice (397)
Career pathing (2)
CAR-T (31)
Cell therapy (103)
Cervical cancer (2)
Clinical research (18094)
Collaboration (179)
Compensation (174)
Complete response letters (2)
COVID-19 (322)
CRISPR (7)
C-suite (105)
Cystic fibrosis (17)
Data (553)
Depression (7)
Diabetes (49)
Diagnostics (2134)
Digital health (4)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (42688)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (39737)
Executive appointments (321)
FDA (4614)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (188)
Gene editing (15)
Generative AI (2)
Gene therapy (52)
GLP-1 (116)
Government (450)
Guidances (17)
Healthcare (5240)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (7)
Infectious disease (342)
Inflammatory bowel disease (25)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (16)
Interviews (53)
IPO (8149)
IRA (3)
Job creations (1342)
Job search strategy (365)
Kidney cancer (6)
Labor market (4)
Layoffs (109)
Leadership (5)
Legal (2731)
Liver cancer (18)
Lung cancer (56)
Lymphoma (28)
Management (10)
Manufacturing (49)
MASH (27)
Medical device (4099)
Medtech (4100)
Mergers & acquisitions (8465)
Metabolic disorders (131)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (2)
Neuroscience (354)
NextGen: Class of 2025 (1728)
Non-profit (742)
Northern California (924)
Now hiring (3)
Obesity (56)
Opinion (31)
Ovarian cancer (20)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (23)
Patient recruitment (27)
Peanut (5)
People (26052)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (5238)
Phase II (7707)
Phase III (6419)
Pipeline (565)
Policy (8)
Postmarket research (834)
Preclinical (2008)
Press Release (66)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (107)
Rare diseases (68)
Real estate (2009)
Recruiting (8)
Regulatory (5860)
Reports (15)
Research institute (328)
Resumes & cover letters (68)
Rett syndrome (3)
RSV (4)
Schizophrenia (23)
Series A (27)
Series B (23)
Sickle cell disease (7)
Southern California (703)
Special edition (1)
Spinal muscular atrophy (29)
Sponsored (3)
Startups (1098)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (7151)
Vaccines (46)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (16)
Last 7 days (110)
Last 30 days (696)
Last 365 days (10619)
2025 (2985)
2024 (11671)
2023 (13931)
2022 (20385)
2021 (21246)
2020 (19729)
2019 (14249)
2018 (11009)
2017 (11221)
2016 (10365)
2015 (13654)
2014 (10706)
2013 (8455)
2012 (9082)
2011 (9476)
2010 (9338)
Location
Africa (195)
Alabama (14)
Alaska (2)
Arizona (59)
Arkansas (2)
Asia (12083)
Australia (1696)
California (1934)
Canada (702)
China (71)
Colorado (81)
Connecticut (91)
Delaware (32)
Europe (35757)
Florida (273)
Georgia (33)
Idaho (23)
Illinois (120)
India (9)
Indiana (64)
Iowa (2)
Japan (69)
Kansas (25)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (235)
Massachusetts (1604)
Michigan (85)
Minnesota (138)
Mississippi (1)
Missouri (22)
Montana (16)
Nebraska (13)
Nevada (23)
New Hampshire (15)
New Jersey (559)
New Mexico (5)
New York (481)
North Carolina (348)
North Dakota (2)
Northern California (924)
Ohio (57)
Oklahoma (5)
Oregon (4)
Pennsylvania (370)
Puerto Rico (1)
Rhode Island (13)
South America (303)
South Carolina (4)
Southern California (703)
Tennessee (38)
Texas (223)
Utah (60)
Virginia (55)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (21)
244,635 Results for "amarin corporation plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
April 7, 2025
·
3 min read
Pharm Country
Amarin Board of Directors Announces CEO Transition
Amarin Corporation plc today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as President and Chief Executive Officer (CEO).
June 4, 2024
·
5 min read
Press Releases
Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action
March 12, 2025
·
21 min read
Press Releases
Amarin Receives National Reimbursement for VAZKEPA® in Austria
February 26, 2025
·
5 min read
Pharm Country
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Amarin Corporation plc (NASDAQ: AMRN) today announced that Patrick Holt, Amarin’s president and chief executive officer, is scheduled to participate in fireside chat at the 2024 H.C. Wainwright 2nd Annual BioConnect Investor Conference.
May 6, 2024
·
2 min read
Pharm Country
Amarin Announces Results of Annual General Meeting of Shareholders
Amarin Corporation plc announced shareholder approval of all proposed resolutions specified at its 2024 Annual General Meeting.
April 22, 2024
·
5 min read
Pharm Country
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.
Amarin Corporation plc (NASDAQ:AMRN) today announces that the Greek Ministry of Health has approved VAZKEPA.
May 28, 2024
·
6 min read
Business
Amarin Reports First Quarter 2024 Business Update and Financial Results
Amarin Corporation plc, provided an update on the Company’s business highlights and announced financial results for the quarter ended March 31, 2024.
May 1, 2024
·
19 min read
Business
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss its first quarter 2024 results followed by Q&A on Wednesday, May 1st , 2024, at 8:00 a.m. ET.
April 15, 2024
·
2 min read
Pharm Country
Amarin Chairman & CEO Issue Letter to Shareholders - Jan 22, 2024
Amarin Corporation plc announced that the Company’s Chairman of the Board, Odysseas Kostas, M.D., and President & CEO, Patrick Holt, issued the following letter to Amarin shareholders.
January 22, 2024
·
5 min read
1 of 24,464
Next
